Hudie Wei

8PUBLICATIONS
9CO-AUTHORS
Molecular targetsProteins and peptidesContaminant hydrology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 03, 2025
Deciphering molecular specificity in MCL-1/BAK interaction and its implications for designing potent MCL-1 inhibitors.

Hudie Wei, Haolan Wang, Shuang Xiang

|Jan 28, 2025
Characterization of Bozitinib as a potential therapeutic agent for MET-amplified gastric cancer.

Hang Lin, Lingzhi Qu, Hudie Wei

|Jan 03, 2024
Structural basis and selectivity of sulfatinib binding to FGFR and CSF-1R.

Qianmeng Lin, Shuyan Dai, Lingzhi Qu

|Jul 18, 2023
Structures of p53/BCL-2 complex suggest a mechanism for p53 to antagonize BCL-2 activity.

Hudie Wei, Haolan Wang, Genxin Wang

|Jan 25, 2023
Characterization of the cholangiocarcinoma drug pemigatinib against FGFR gatekeeper mutants.

Qianmeng Lin, Xiaojuan Chen, Lingzhi Qu

|Jan 25, 2023
Structure-based design of a dual-warhead covalent inhibitor of FGFR4.

Xiaojuan Chen, Huiliang Li, Qianmeng Lin

Pageof 2